Chaim Lebovits Brainstorm Cell Therapeutics Inc. (BCLI) insider trading activity

BCLI Quotes by TradingView

Chaim Lebovits is President & CEO of BRAINSTORM CELL THERAPEUTICS INC.. Currently has a direct ownership of 80,960 shares of BCLI, which is worth approximately $156,252. The most recent transaction as insider was on Oct 01, 2024, when has been sold 1,836 shares (Common Stock) at a price of $3.43 per share, resulting in proceeds of $6,297. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 81K
93.05% 3M change
72.4% 12M change
Total Value Held $156,252

Chaim Lebovits Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 01 2024
BUY
Open market or private purchase
$6,297 $3.43 p/Share
1,836 Added 2.22%
80,960 Common Stock
Sep 30 2024
BUY
Open market or private purchase
$5,060 $0.23 p/Share
22,000 Added 1.82%
1,186,865 Common Stock
May 28 2024
BUY
Grant, award, or other acquisition
$7,800 $0.52 p/Share
15,000 Added 1.27%
1,164,865 Common Stock
May 22 2024
BUY
Grant, award, or other acquisition
$16,000 $0.64 p/Share
25,000 Added 2.13%
1,149,865 Common Stock
May 21 2024
BUY
Grant, award, or other acquisition
$14,499 $0.58 p/Share
25,000 Added 2.17%
1,124,865 Common Stock
May 13 2024
BUY
Grant, award, or other acquisition
$4,900 $0.49 p/Share
10,000 Added 0.9%
1,099,865 Common Stock
May 11 2024
BUY
Grant, award, or other acquisition
$4,700 $0.47 p/Share
10,000 Added 0.91%
1,089,865 Common Stock
May 10 2024
BUY
Grant, award, or other acquisition
$9,200 $0.46 p/Share
20,000 Added 1.82%
1,079,865 Common Stock
May 07 2024
BUY
Grant, award, or other acquisition
$24,531 $0.37 p/Share
66,300 Added 5.89%
1,059,865 Common Stock
May 06 2024
BUY
Grant, award, or other acquisition
$51,300 $0.38 p/Share
135,000 Added 11.96%
993,565 Common Stock
Apr 19 2024
BUY
Grant, award, or other acquisition
$7,800 $0.52 p/Share
15,000 Added 1.72%
858,565 Common Stock
Apr 18 2024
BUY
Grant, award, or other acquisition
$60,988 $0.53 p/Share
115,072 Added 12.0%
843,565 Common Stock
Apr 17 2024
BUY
Grant, award, or other acquisition
$71,500 $0.55 p/Share
130,000 Added 15.14%
728,493 Common Stock
Mar 11 2024
BUY
Grant, award, or other acquisition
-
305,198 Added 33.77%
598,493 Common Stock
Aug 02 2023
BUY
Grant, award, or other acquisition
-
31,185 Added 9.61%
293,295 Common Stock
Apr 20 2023
BUY
Grant, award, or other acquisition
-
75,000 Added 22.25%
262,110 Common Stock
Sep 18 2022
BUY
Grant, award, or other acquisition
-
31,185 Added 14.29%
187,110 Common Stock
Dec 10 2021
BUY
Grant, award, or other acquisition
-
31,185 Added 16.67%
155,925 Common Stock
CL

Chaim Lebovits

President & CEO
New York, NY

Track Institutional and Insider Activities on BCLI

Follow BRAINSTORM CELL THERAPEUTICS INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BCLI shares.

Notify only if

Insider Trading

Get notified when an Brainstorm Cell Therapeutics Inc. insider buys or sells BCLI shares.

Notify only if

News

Receive news related to BRAINSTORM CELL THERAPEUTICS INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BCLI